Saripidem
Alternative Names: SL 850274Latest Information Update: 06 Aug 2002
Price :
$50 *
At a glance
- Originator Sanofi-Synthelabo
- Class Anxiolytics; Neuroprotectants
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 27 Aug 1999 Sanofi and Synthélabo have now merged to form Sanofi-Synthélabo